Astrocytomas

Glioma is a catchall term that includes many different types of tumor, including astrocytomas, oligodendrogliomas, and ependymomas, according to the American Cancer Society. ❋ Unknown (2009)

It is also known as high grade or grade 4 astrocytomas. ❋ Unknown (2008)

Dr. Olney personally advised me in 1978 of his preliminary Aspartame research that identified chromatin clumping of the DNA similar to the DNA changes of gliomas of the most aggressive type of multicentric astrocytomas. ❋ Unknown (2008)

These tumors, including the anaplastic astrocytomas and glioblastomas, can arise anywhere in the brain and are much more aggressive than astrocytomas. ❋ Unknown (2005)

The two major types of glial tumors are astrocytomas and ependymonas. ❋ Unknown (2005)

The plasma concentrations at which astrocytomas occurred in rats was at five times the anticipated human clinical exposure.

One of these was the occurrence and importance of mammary tumors in female rats and the other was detection of astrocytomas in the brains of male rats.

To more accurately estimate the exposure margin for brain astrocytomas observed in male rats.

Everolimus treatment of subependymal giant cell astrocytomas (SEGAs) associated with tuberous sclerosis complex (TSC): the EXIST-1 trial. ❋ Unknown (2011)

Afinitor is marketed in the US and approved in the EU (trade name: Votubia) for the treatment of subependymal giant cell astrocytomas (SEGA), a benign brain tumor associated with tuberous sclerosis (TS).

In a separate study, Afinitor also showed success in reducing the size of subependymal giant cell astrocytomas - non-cancerous tumors - in patients with tuberous sclerosis. ❋ Unknown (2011)

Phase II study show Afinitor® tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas, benign brain tumors ... ❋ Unknown (2010)